Treatment of hepatocellular carcinoma

Digestion

Volumn 59, Issue 5, 1998, Pages 556-562

  Tang, Zhao You ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Recurrence; Regional cancer therapies; Resection; Second look resection; Transcatheter arterial chemoembolization; Treatment

Indexed keywords

ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; DIAGNOSTIC IMAGING; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REOPERATION; REVIEW; SURGICAL APPROACH;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL;

EID: 0031903586     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007531     Document Type: Review

References (83)

1. Kuroishi T, Hayakawa N, Kurihara M, Aoki K: Cancer mortality in 33 countries of the world (1953-1987); in Tominaga S, Aoki K, Fujimoto I, Kuraihara M (eds): Cancer Mortality and Morbidity Statistics (Japan and the World -1994). Tokyo, Jpn Sci Soc Press, 1994, pp 167-230.
2. Li LD, Zhang SW, Lu FZ, Mu R, Zhang XD, Huang-Pu XM, Sun J, Zhou YS, Xia Y, Dai SD, Rao KQ, Chen YD, Sun AM, Xue ZF: Research on characteristics of mortality spectrum and type composition of malignant tumors in China. Chin J Oncol 1997;19:323-328.
3. Iwatsuki S, Starzl TE: Role of liver transplantation in the treatment of hepatocellular carcinoma. Semin Surg Oncol 1993;9:337-340.
4. Tang ZY (ed): Subclinical Hepatocellular Carcinoma. Berlin, Springer, 1985.
5. Tang ZY, Ying YY, Gu TJ: Hepatocellular carcinoma: Changing concepts in recent years; in Popper H, Schaffner F (eds): Progress in Liver Diseases. New York, Grune & Stratton, 1982, vol 7, pp 637-647.
6. Tang ZY, Yu YQ, Zhou XD: An important approach to prolonging survival further after radical resection of AFP positive hepatocellular carcinoma. J Exp Clin Cancer Res 1984;3: 359-366.
7. Tang ZY, Yu YQ, Zhou XD, Ma ZC, Lu JZ, Liu KD, Lin ZY, Yang BH, Fan Z, Hou Z, Zhang M: Cytoreduction and sequential resection: A hope for unresectable primary liver cancer. J Surg Oncol 1991;47:27-31.
8. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997;47: 5-27.
9. Liver Cancer Study Group of Japan: Survey and follow-up study of primary liver cancer in Japan - report 11. Acta Hepatol Jpn 1995;36: 208-218.
10. Tang ZY: Treatment of unresectable hepatocellular carcinoma: Cytoreduction by chemotherapy, hepatic artery ligation, radioimmunotherapy, and other methods; in Okuda K, Tabor E (eds): Liver Cancer. New York, Churchill-Livingstone, 1997, pp 537-541.
11. Du JH, Wang XH, Li XC: Clinical investigation of late treatment results of primary hepatocellular carcinoma (in Chinese). J Hepatobiliary Panc Splenic Surg 1995;1:178-180.
12. Curley SA, Izzo F, Gallipoli A, Bellis M, deCremona F, Parisi V: Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular carcinoma. Ann Surg 1995;222:375-383.
13. Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E: Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996;78:977-985.
14. Sarasin FP, Giostra E, Hadengue A: Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med 1996;101:422-434.
15. Yang BH, Zhang BH, Xu YC, Wang WP, Shen YF, Zhang AR, Xu Z: Prospective study of early detection for primary liver cancer. J Cancer Res Clin Oncol 1997;123:357-360.
16. Tang ZY, Yu YQ, Zhou XD, Ma ZC, Yang R, Lu JZ, Lin ZY, Yang BH: Surgery of small hepatocellular carcinoma: Analysis of 144 cases. Cancer 1989;64:536-541.
17. Makuuchi M, Kosuge T, Takayama T, Yamasaki S, Kakazu T, Miyagawa S, Kawasaki S: Surgery of small liver cancers. Semin Surg Oncol 1993;9:298-304.
18. Inoue K, Makuuchi M, Takayama T, Harihara Y, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Hasegawa H: Surgical treatment of small hepatocellular carcinoma. Jpn J Cancer Chemother 1996;23:849-854.
19. Wu MC, Chen H, Yao XH, Yang JM, Yang GS, Shen F: Surgical treatment of primary liver cancer (in Chinese). Chin J Surg 1996;34:707-710.
20. Zhou XD, Tang ZY, Yu YQ, Yang BH, Lin ZY, Lu JZ, Ma ZC: Long-term results of surgery for small primary liver cancer in 514 adults. J Cancer Res Clin Oncol 1996;122:59-62.
21. Lai ECS, Fan ST, Lo CM, Chu KM, Liu CL, Wong J: Hepatic resection for hepatocellular carcinoma. Ann Surg 1995;221:291-298.
22. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M: Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995;169:28-35.
23. Bismuth H, Chiche L, Castaing D: Surgical treatment of hepatocellular carcinomas in non-cirrhotic liver: Experience with 68 liver resections. World J Surg 1995;19:35-41.
24. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K: Results of 280 liver resections for hepatocellular carcinoma. Surgery 1996;131:71-76.
25. Du JH, Wang XH, Li XC: Clinical investigation of late treatment results of primary hepatocellular carcinoma (in Chinese). J Hepatobiliary Panc Splenic Surg 1995;1:178-180.
26. Yu YQ, Tang ZY, Ma ZC, Zhou XD, Mack P: Resection of segment VIII of liver for treatment of primary liver cancer. Arch Surg 1993; 128:224-227.
27. Yang M-C, Lee P-H, Sheu J-C, Lai M-Y, Hu R-H, Wei C-K: Surgical treatment of hepatocellular carcinoma originating from the caudate lobe. World J Surg 1996;20:562-566.
28. Tanaka A, Morimoto T, Yamaoka Y: Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein. Hepato-Gastroenterology 1996;43: 637-643.
29. Shimamura T, Nakajima Y, Une Y, Namieno T, Ogasawara K, Yamashita K, Haneda T, Nakanishi K, Kimura T, Matsushita M, Sato N, Uchino J: Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: A clinical study. Surgery 1997;121:135-141.
30. Sun JH, Ito T, Zhang P, Matsuda H, Wang ZT: Enhancement of tumor growth after partial hepatectomy and blood transfusion. Chin J Cancer Res 1996;8:196-199.
31. Noun R, Jagot P, Farges O, Sanvanet A, Belghiti J: High preoperative serum alanine transferase levels: Effect on the risk of liver resection in Child grade A cirrhotic patients. World J Surg 1997;21:390-395.
32. Zhou XD, Tang ZY: Cryotherapy for primary liver cancer. Semin Surg Oncol 1998;14:171-174.
33. Tang ZY, Yu YQ, Zhou XD, Ma ZC, Yang BH, Lin ZY, Lu JZ, Liu KD, Fan Z, Zeng ZC: Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection. World J Surg 1995;19:47-52.
34. Tang ZY, Yu YQ, Zhou XD, Ma ZC, Lu JZ, Lin ZY, Liu KD, Ye SL, Yang BH, Wang HW, Sun HC: Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: Evaluation with analysis of 72 patients. World J Surg 1995;19:784-789.
35. Tang ZY, Liu KD, Bao YM, Lu JZ, Yu YQ, Ma ZC, Zhou XD, Yang R, Gan YH, Lin ZY, Fan Z, Hou Z: Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection. Cancer 1990;65:211-215.
36. Lu JZ, Li BX, Liu KD, Yu YQ, Tang ZY: Alternating chemotherapy and fractionated radiotherapy as a modality for the treatment of primary liver cancer. Chin J Cancer Res 1994;6: 69-73.
37. Yu YQ, Xu DB, Zhou XD, Lu JZ, Tang ZY, Mack P: Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 1993;71:62-65.
38. Sitzmann JV, Abrams R: Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg 1993;217:149-155.
39. Elias D, Lasser P, Rougier P, Ducreux M, Bognel C, Roche A: Frequency, technical aspects, results and indications of major hepatectomy after prolonged intraarterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995;180:213-219.
40. Elli M, Cristaldi M, Mezzabotta M, Montecamozzo G, Porretta T, Cornalba GP, Vago L, Taschieri AM: Transcatheter arterial chemoembolization in cytoreduction of inoperable hepatocarcinoma. Hepato-Gastroenterology 1997;44:522-524.
41. Wang YH, Liu YX, Feng YQ, Ji XL, Zhao HL: Secondary resection of primary liver carcinoma after transcatheter hepatic arterial embolization (TAE): Clinicopathological features and postoperative course of 33 cases (in Chinese). J Hepatobil Panc Splenic Surg 1997;3:68-73.
42. Bismuth H, Chiche L: Comparison of hepatic resection and transplantation in the treatment of liver cancer. Semin Surg Oncol 1993;9:341-345.
43. Selby R, Kadry Z, Carr B, Tzakis A, Madariaga JR, Iwatsuki S: Liver transplantation for hepatocellular carcinoma. World J Surg 1995;19: 53-58.
44. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzett F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996;334:693-699.
45. Ishizone S, Makuuchi M, Kawasaki S, Matsunami H, Terada M, Kitahara S: Partial liver transplantation from living related donor: Clinical experience at Shinshu University. Asian J Surg 1994;17:63-71.
46. Bronowicki J-P, Vetter D, Doffoel M: Chemoembolization of hepatocellular carcinoma; in Okuda K, Tabor E (eds): Liver Cancer. New York, Churchill-Livingstone, 1997, pp 463-469.
47. Stefanini GF, Amorati P, Biselli M, Mucci F, Celi A, Arienti V, Roversi R, Rossi C, Re G, Gasbarrini G: Efficacy of transarterial targeted treatment on survival of patients with hepatocellular carcinoma: An Italian experience. Cancer 1995;75:2427-2434.
48. Cheng LF, Wang ZQ, Cai FC, Zhang YH, Liu YD: Analysis of survival of 240 patients with unresectable primary hepatocellular carcinoma treated with hepatic artery chemo-embolization (in Chinese). Chin J Oncol 1996;18:362-365.
49. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY: The safety and efficacy of transcatheter chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction - a prospective controlled study. Cancer 1997;79:2087-2094.
50. Bronowicki J-P, Boudjema K, Chone L, Nisand G, Bazin C, Pfumio F, Uhl G, Wenger J-J, Jaeck D, Boissel P, Bigard MA, Gaucher P, Vetter D, Doffoel M: Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol 1996;24:293-300.
51. Uchida H, Matsuo N, Sakaguchi H, Nishimine K, Anai H, Ohishi H: Chemoembolotherapy for small hepatocellular carcinoma. Jpn J Cancer Chemother 1996,23:840-848.
52. Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, Saito S, Kiba T, Okazaki H, Sekihara H: The long-term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma. Cancer 1998;82:78-85.
53. Liou T-C, Shih S-C, Kao C-R, Chou S-Y, Lin S-C, Wang H-Y: Pulmonary metastasis of hepatocellular carcinoma associated with transcatheter arterial chemoembolization. J Hepatol 1995;23:563-568.
54. Katsushima S, Inokuma T, Oi H, Okamura J, Higashi T, Takeuchi R, Hidaka A, Shigeno C, Iida Y, Konishi J: Acute hepatic failure following transcatheter arterial embolization for the treatment of hepatocellular carcinoma. Digestion 1997;58:189-195.
55. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolond L, Pompili M, Brunello F, Lazzaroni S, Torzilli G, Zucchi A: Hepatocellular carcinoma with cirrhosis in 746 patients: Longterm results of percutaneous ethanol injection. Radiology 1995;197:101-108.
56. Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S: Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996;77:1792-1796.
57. Ohnishi K, Nomura F, Ito S, Fujiwara K: Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: Study of 91 cases. Hepatology 1996;23: 994-1002.
58. Sato M, Watanabe Y, Ueda S, Iseki S, Abe Y, Sato N, Kimura S, Okubo K, Onji M: Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology 1996;110:1507-1514.
59. Cheng SQ, Zhou XD, Tang ZY, Yu Y, Bao SS, Qian DC: Iodized oil enhances the thermal effect of high-intensity focused ultrasound on ablating experimental liver cancer. J Cancer Res Clin Oncol 1997;123:639-644.
60. Robertson JM, Lawrence TS, Dworzanin LM, Andrews JC, Walker S, Kessler ML, DuRoss DJ, Ensiminger WD: Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993;11:1286-1293.
61. Tang ZY, Zeng ZC, Liu KD, Yu YQ, Lu JZ, Xie H: Intrahepatic arterial 1-131 anti-hepatocellular carcinoma (HCC) monoclonal anti-body combined with hepatic artery ligation for treatment of unresectable HCC. Antibody Immunoconj Radiophar 1993;6:167-175.
62. Zeng ZC,Tang ZY, Liu KD, Lu JZ, Cai XJ, Xie H: Human anti-(murinelg) antibody responses in patients with hepatocellular carcinoma receiving Hepama-1 mAb: Preliminary results and discussion. Cancer Immunol lmmunother 1994;39:332-336.
63. Zhou G, Liu KD, Tang ZY, Chen YH, Wu XF, Schroder CH: Reconstruction and expression of chimeric anti-HBx antibody in Escherichia coli. J Cancer Res Clin Oncol 1997;123:325-330.
64. 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997;26:1156-1161.
65. Okada S: Chemotherapy for hepatocellular carcinoma; in Okuda K, Tabor E (eds): Liver Cancer. New York, Churchill-Livingstone, 1997, pp 441-447.
66. Castells A, Bruix J, Bru C, Ayuso C, Roca M, Boix L, Vilana R, Rodes J: Treatment of hepatocellular carcinoma with tamoxifen: A double blind placebo controlled trial in 120 patients. Gastroenterology 1995;109:917-922.
67. Chao Y, Chan W-K, Wang S-S, Lai K-H, Chi C-W, Lin C-Y, Chan A, Whang-Peng J, Lui W-Y, Lee S-D: Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:277-281.
68. Yamauchi K, Haruta I, Miyazono Y, Furukawa T, Kimura T, Shimizu T, Yamaguchi N, Hayashi N, Aruga A, Takasaki K: Clinical evaluation of CTL therapy for patients with liver cancer. Biotherapy 1997;11:226-228.
69. Schuster MJ, Wu GY: Gene therapy for hepatocellular carcinoma: Progress but many stones yet unturned. Gastroenterology 1997;112:656-659.
70. Harada T, Matsuo K, Inoue T, Tamesue S, Inoue T: Multimodal treatment of stage IVa hepatocellular carcinoma. Hepato-Gastroenterology 1996;43:1154-1158.
71. Lygidakis NJ, Tsiliakos S, Talaat A, Matsakis G, Tepetes K: Multidisciplinary management of hepatocellular carcinoma. Hepato-Gastroenterology 1997;44:268-273.
72. Zhou XD, Yu YQ, Tang ZY, Yang BH, Lu JZ, Lin ZY, Ma ZC, Xu DB, Zhang BH, Zheng YX, Tang CL: Surgical treatment of recurrent hepatocellular carcinoma. Hepato-Gastroenterology 1993;40:333-336.
73. Zhang BH, Zhou XD, Yu YQ, Tang ZY: Risk factors for recurrence in patients with hepatocellular carcinoma after radical resection. Chin J Cancer Res 1994;6:58-62.
74. Shirabe K, Takenaka K, Taketomi A, Kawahara N, Yamamoto K, Shimada M, Sugimachi K: Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996;77:1050-1055.
75. Tanaka T, Yamanaka N, Oriyama T, Furukawa K, Okamoto E: Factors regulating tumor pressure in hepatocellular carcinoma and implications for tumor spread. Hepatology 1997; 26:283-287.
76. Hino N, Higashi K, Nouso K, Nakatsukasa H, Urabe Y, Kinugasa N, Yoshida K, Ashida K, Ohguchi S, Tsuji T: Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma - evaluation in US-guided specimens. Hepato-Gastroenterology 1997;44: 245-250.
77. Nagasue N, Yu L, Yukaya H, Kohno H, Nakamura T: Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: Impact on intrahepatic recurrence after hepatic resection. Br J Surg 1995; 82:542-547.
78. Funaki NO, Tanaka J, Seto S-I, Kasamatsu T, Kaido T, Imamura M: Hematogenous spreading of hepatocellular carcinoma cells - possible participation in recurrence in the liver. Hepatology 1997;25:564-568.
79. Zhou XD, Tang ZY, Yu YQ, Yang BH, Lu JZ, Lin ZY, Ma ZC, Zhang BH: Recurrence after resection of alpha fetoprotein positive hepatocellular carcinoma. J Cancer Res Clin Oncol 1994;120:369-373.
80. Lee P-H, Lin W-J, Tsang Y-M, Hu R-H, Shen J-C, Lai M-Y, Hsu H-C, May W, Lee C-S: Clinical management of recurrent hepatocellular carcinoma. Ann Surg 1995;222:670-676.
81. Peng SY, Lu CD, Jiang XC, Peng CH: Effect of preoperative hepatic chemoembolization on reduction of recurrence rate after resection of hepatocellular carcinoma (in Chinese). J Hepatol Panc Splen Surg 1996;2:12-15.
82. Uchino J, Une Y, Kawata A, Wakisaka Y, Hosokawa M: Postoperative chemoimmunotherapy for the treatment of liver cancer. Semin Surg Oncol 1993;19:332-336.
83. Takenaka K, Yoshida K, Nishizaki T, Korenaga D, Hiroshige K, Ikeda T, Sugimachi K: Post-operative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 1995;169:400-405.